Over-expression of TSC-22 (TGF-β stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line

Laboratory Investigation

Volumn 80, Issue 6, 2000, Pages 955-963

  Uchida, Daisuke ^a   Kawamata, Hitoshi ^a   Omotehara, Fumie ^a   Miwa, Yoshihiro ^a   Hino, Satoshi ^a   Begum, Nasima Mila ^a   Yoshida, Hideo ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; COMPLEMENTARY DNA; FLUOROURACIL; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PEPLEOMYCIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOPLASM; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SALIVARY GLAND CANCER;

EID: 0033946261     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780098     Document Type: Article

References (27)

1. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, and Mitchell JB (1987). Evaluation of a tetrazolium-based semi-automated calorimetric assay: Assessment of chemosensitivity testing. Cancer Res 47:936-942.
2. Cirielli C, Riccioni T, Yang C, Pili R, Gloe T, Chang J, Inyaku K, Passaniti A, and Capogrossi MC (1995). Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int J Cancer 27:673-679.
3. Dobens LL, Hsu T, Twombly V, Gelbart WM, Raftery LA, and Kafatos FC (1997). The Drosophila bunched gene is a homologue of the growth factor stimulated mammalian TSC-22 sequence and is required during oogenesis. Mech Dev 65: 197-208.
4. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, and Roth JA (1994). Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54:2287-2291.
5. Furuhata T, Tokino T, Urano T, and Nakamura Y (1996). Isolation of a novel GPI-anchored gene specifically regulated by p53; correlation between its expression and anti-cancer drug sensitivity. Oncogene 13:1965-1970.
6. Hamil KG and Hall SH (1994). Cloning of rat Sertoli cell follicle-stimulating hormone primary response complementary deoxyribonucleic acid: Regulation of TSC-22 gene expression. Endocrinology 134:1205-1212.
7. Jay P, Ji JW, Marsollier C, Taviaux S, Berge-Lefranc JL, and Berta P (1996). Cloning of the human homologue of the TGF-β-stimulated clone 22 gene. Biochem Biophys Res Commun 222:821-826.
8. Kagawa K, Inoue T, Tokino T, Nakamura Y, and Akiyama T (1997). Overexpression of GML promotes radiation-induced cell cycle arrest and apoptosis. Biochem Biophys Res Commun 241:481-485.
9. Kania A, Salzberg A, Bhat M, D'Evelyn D, He Y, Kiss I, and Bellen HJ (1995). P-element mutations affecting embryonic peripheral nervous system development in Drosophila melanogaster. Genetics 139:1663-1678.
10. Kawamata H, Nakashiro K, Uchida D, Hino S, Omotehara F, Yoshida H, and Sato M (1998). Induction of TSC-22 by treatment with a new anti-cancer drug, Vesnarinone, in a human salivary gland cancer cell. Br J Cancer 77:71-78.
11. Kester H A, van der Leede BM, van der Saag PT, and van der Burg B (1997). Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J Biol Chem 272:16637-16643.
12. Kimura Y, Furuhata T, Shiratsuchi T, Nishimori H, Hirata K, Nakamura Y, and Tokino T (1997a). GML sensitizes cancer cells to Taxol by induction of apoptosis. Oncogene 15:1369-1374.
13. Kimura Y, Furuhata T, Urano T, Hirata K, Nakamura Y, and Tokino T (1997b). Genomic structure and chromosomal localization of GML (GPI-anchored molecule-like protein), a gene induced by p53. Genomics 41:477-480.
14. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, and Jacks T (1994). p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810.
15. Nakashiro K, Kawamata H, Hino S, Uchida D, Miwa Y, Hamano H, Omotehara F, Yoshida H, and Sato M (1998). Down-regulation of TSC-22 (transforming growth factor β-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res 58:549-555.
16. Ohta S, Shimekake Y, and Nagata K (1996). Molecular cloning and characterization of a transcription factor for the C-type natriuretic peptide gene promoter. Eur J Biochem 242:460-466.
17. Ohta S, Yanagihara K, and Nagata K (1997). Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor β. Biochem J 324:777-782.
18. Righetti SC, Della-Torre G, Pilotti S, Menard S, Ottone F, Colnaghi Ml, Pierotti MA, Lavarino C, Cornarotti M, Oriana S, Bohm S, Bresciani GL, Spatti G, and Zunino F (1996). A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Cancer Res 56:689-693.
19. Roth JA, Swisher SG, Merritt JA., Lawrence DD, Kemp BL, Carrasco CH, EI-Naggar AK, Fossella FV, Glisson BS, Hong WK, Khurl FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB, Schrump DS, Shin DM, and Walsh GL (1998). Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Semin Oncol 25:33-37.
20. Schuler M, Rochlitz C, Horowitz JA, Schlegel J, Perruchoud AP, Kommoss F, Bolliger CT, Kauczor HU, Dalquen P, Fritz MA, Swanson S, Herrmann R, and Huber C (1998). A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum Gene Ther 9:2075-2082.
21. Shibanuma M, Kuroki T, and Nose K (1992). Isolation of a gene encoding putative leucine zipper structure that is induced by transforming growth factor β1 and other growth factors. J Biol Chem 267:10219-10224.
22. Sillard R, Schulz-Knappe P, Vogel P, Raida M, Bensch KW, Forssmann WG, and Mutt V (1993). A novel 77-residue peptide from porcine brain contains a leucine-zipper motif and is recognized by an antiserum to delta-sleep-inducing peptide. Eur J Biochem 216:429-435.
23. Treisman JE, Lai ZC, and Rubin GM (1995). Shortsighted acts in the decapentaplegic pathway in Drosophila eye development and has homology to a murine TGF-β-responsive gene. Development 121:2835-2845.
24. Vogel P, Mägert HJ, Cieslak A, Adermann K, and Forssmann WG (1996). hDIP-a potential transcriptional regulator related to murine TSC-22 and Drosophila shortsighted (shs)-is expressed in a large number of human tissues. Biochim Biophys Acta 1309:200-204.
25. Yanagawa T, Hayashi Y, Yoshida H, Yura Y, Nagamine S, Bando T, and Sato M (1986). An adenoid squamous carcinoma-forming cell line established from an oral keratinizing squamous cell carcinoma expressing carcinoembryonic antigen. Am J Pathol 124:496-509.
26. Yang C, Cirielli C, Capogrossi MC, and Passaniti A (1995). Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res 55:4210-4213.
27. Yang TT, Cheng L, and Kain SR (1996). Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res 24:4592-4593.